Overweight individuals with hepatic steatosis displayed increased immunoreactivity for leptin, and lower intensity of immunoreaction against visfatin and chemerin in the liver compared to subjects without histopathological changes in the organ. This evidence concerns the gene LEP and fatty liver disease.